Khasraw, M., Abrey, L. E., Lassman, A. B., Hormigo, A., Nolan, C., Gavrilovic, I. T., … Omuro, A. M. (2010). PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV). In NEURO-ONCOLOGY (Vol. 12, pp. 72–72). Hollywood, FL: OXFORD UNIV PRESS INC.

Khasraw, Mustafa, Lauren E. Abrey, Andrew B. Lassman, Adilia Hormigo, Craig Nolan, Igor T. Gavrilovic, Ingo K. Mellinghoff, Anne S. Reiner, Lisa DeAngelis, and Antonio M. Omuro. “PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV).” In NEURO-ONCOLOGY, 12:72–72. OXFORD UNIV PRESS INC, 2010.

Khasraw M, Abrey LE, Lassman AB, Hormigo A, Nolan C, Gavrilovic IT, et al. PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV). In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2010. p. 72–72.

Khasraw, Mustafa, et al. “PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV).” NEURO-ONCOLOGY, vol. 12, OXFORD UNIV PRESS INC, 2010, pp. 72–72.

Khasraw M, Abrey LE, Lassman AB, Hormigo A, Nolan C, Gavrilovic IT, Mellinghoff IK, Reiner AS, DeAngelis L, Omuro AM. PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV). NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2010. p. 72–72.